Application of cattle placental stem cells for treating ovarian follicular cyst

doi:10.4252/wjsc.v12.i11.1366

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7268)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-1) series.

Item

Count

PDF

243

WORD

146

HTML

3217

Figures (1-8)

406

Tables (1-1)

460

Sum=4472

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

381

Download

951

Sum=1332

Publishing Process of This Article

Item

Count

Browse

477

Download

987

Sum=1464

Nov 26, 2020 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Stem Cells. Nov 26, 2020; 12(11): 1366-1376
Published online Nov 26, 2020. doi: 10.4252/wjsc.v12.i11.1366

Full Size Figure Download Figure

Figure 4 Flow cytometry analysis of surface marker of cattle placental stem cells. A: Cattle placental stem cells (CPSCs) expressed 98.6% CD44, which is a mesenchymal stem cell marker; B: CPSCs expressed 2.0% CD4, which is a T lymphocyte marker; C: CPSCs expressed 3.2% CD105, which is an angiogenesis-related marker.

Citation: Peng SY, Wu TH, Lin TY, Hii LY, Chan KS, Fu TY, Chang SC, Shen PC, Liu KY, Shaw SW.. Application of cattle placental stem cells for treating ovarian follicular cyst. World J Stem Cells 2020; 12(11): 1366-1376
URL: https://www.wjgnet.com/1948-0210/full/v12/i11/1366.htm
DOI: https://dx.doi.org/10.4252/wjsc.v12.i11.1366